RADAR Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 26, 2017

Primary Completion Date

June 7, 2019

Study Completion Date

June 7, 2019

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

Computational Mapping Algorithm

This software enables high resolution temporospatial mapping of atria for the identification of drivers of AF. CMA receives data from standard of care, commercially available 3D Mapping Systems (St. Jude Ensite System) and catheters and processes the data in a unique way. Electrogram and anatomy data are fed from the commercially available 3D Mapping System to an adjacent laptop computer, via an Ethernet connection, that is running CMA. CMA then processes the electrogram data and generates a map of where the potential AF driver domains are located and superimposes those potential AF driver domain targets onto the 3D geometry of the anatomy (provided by the 3D mapping system).

Trial Locations (4)

10029

Icahn School of Medicine at Mount Sinai, New York

80045

University of Colorado Medical Center, Denver

80120

South Denver Cardiology, Denver

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

AFTx, Inc.

INDUSTRY

lead

Vivek Reddy

OTHER

NCT03263702 - RADAR Clinical Trial | Biotech Hunter | Biotech Hunter